Press Releases
Press Releases
Nanologicaand Sterling partnership furthers new business venture
Nanologica AB (publ) has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of silica particles. The partnership is the latest step in the development...
Press Releases
Latest technology for cell-based assays now also available for our entry-level product line
Cell-based assays have become an important application in the life science sector, from basic to top-level research. They are widely used in biotech companies and academic research institutions to monitor cell health in real-time. As experiments...
Press Releases
Bio-Techne Launches Mimex™ Gi, An Accessible 3-D Cell Culturing Platform For The Gastrointestinal Tract
Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the gastrointestinal epithelium are quickly being adopted for toxicology, drug...
Press Releases
FDA Approves the World’s Smallest Mechanical Heart Valve for Pediatric Patients With Heart Defects
Abbott announced the U.S. FDA approved the Masters HP™ 15mm rotatable mechanical heart valve, the world's smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. ...
Press Releases
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
Globally, about 800 women die every day of preventable causes related to pregnancy and childbirth; 20 per cent of these women are from India,1 and Postpartum Haemorrhage (PPH) is the leading cause of maternal mortality in India. ...
Press Releases
European Commission approves Hemlibra® (emicizumab) for people with haemophilia A with factor VIII inhibitors
Roche announced that the European Commission has approved Hemlibra® (emicizumab) for routine prophylaxis of bleeding episodes in people with haemophilia A with factor VIII inhibitors. Hemlibra can be used in all age groups. Nearly one in...
Press Releases
Recipharm and Altus Formulation collaborate to offer novel drug delivery technologies for value added medicines
Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug development company, to allow its customers to access new drug delivery technologies and products. Under the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
